People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Newleos Therapeutics, Inc. | — | Biotechnology | Series C | $93.4M | $659.2M | 2025 |
Ming Cheah at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ming Cheah on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Christoph Westphal | 1 | 8 |
| David Donabedian | 1 | 4 |
| Raymond Camahort | 1 | 4 |
| Robert Hadfield | 1 | 2 |
| John McCabe | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.